Table 1.
Characteristic | Streptococcal peritonitis (n = 256) |
No Streptococcal peritonitis (n = 4419) |
p Value |
---|---|---|---|
Age (years) | 62.4 ± 15.8 | 61.5 ± 16.8 | 0.4 |
Women | 134 (52%) | 2415 (55%) | 0.5 |
Racial origin | 0.005 | ||
Caucasian | 176 (69%) | 3405 (77%) | |
Aboriginal/Torres Strait Islander | 28 (11%) | 333 (8%) | |
Maori/Pacific Islander | 8 (3%) | 100 (2%) | |
Asian | 37 (14%) | 404 (9%) | |
Other | 7 (3%) | 177 (4%) | |
BMI (kg/m2) | 25.8 ± 5.1 | 25.9 ± 6.5 | 0.9 |
eGFR at dialysis start (mL/min/1.73 m2) |
6.8 ± 4.3 | 7.1 ± 4.5 | 0.4 |
Late referral | 74 (29%) | 1037 (24%) | 0.047 |
ESRF Cause | 0.4 | ||
Chronic glomerulonephritis | 75 (29%) | 1248 (28%) | |
Diabetic nephropathy | 79 (31%) | 1240 (28%) | |
Renovascular disease | 32 (13%) | 607 (14%) | |
Polycystic kidneys | 17 (7%) | 239 (5%) | |
Reflux nephropathy | 12 (5%) | 185 (4%) | |
Other | 23 (9%) | 622 (14%) | |
Unknown | 18 (7%) | 278 (12%) | |
Current smoker | 26 (10%) | 531 (12%) | 0.2 |
Chronic lung disease | 32 (13%) | 567 (13%) | 0.9 |
Coronary artery disease | 99 (39%) | 1568 (35%) | 0.3 |
Peripheral vascular disease | 59 (23%) | 987 (22%) | 0.8 |
Cerebrovascular disease | 27 (11%) | 581 (13%) | 0.2 |
Diabetes mellitus | 100 (39%) | 1638 (37%) | 0.5 |
Peritoneal Transport Status | <0.001 | ||
High | 31 (12%) | 440 (10%) | |
High average | 94 (37%) | 1617 (37%) | |
Low average | 86 (34%) | 992 (22%) | |
Low | 12 (5%) | 186 (4%) | |
Unknown/Not specified | 33 (13%) | 1184 (27%) | |
Centre size (no. PD patients) | 0.7 | ||
Small (≤ 10) | 2 (1%) | 53 (1%) | |
Small-Med (11–38) | 15 (6%) | 306 (7%) | |
Med-Large (39–98) | 52(20%) | 976 (22%) | |
Large (≥ 99) | 187 (73%) | 3084 (70%) | |
State | 0.2 | ||
New South Wales | 101 (39%) | 1731 (39%) | |
Northern Territory | 5 (2%) | 80 (2%) | |
Queensland | 52 (20%) | 903 (20%) | |
South Australia | 20 (1%) | 275 (6%) | |
Tasmania | 3(1%) | 74 (2%) | |
Victoria | 40 (16%) | 920 (21%) | |
Western Australia | 35 (14%) | 436 (10%) |